Neurology

Persyst 14 EEG Review and Analysis Software

Persyst Development Corporation

FDA-cleared AI medical device

Automatically mark or identify electroencephalograph waveforms for spikes, electrographic seizures, seizure-like events in order to aid in identification of such events and help review and annotation of prolonged EEG traces; All output subject to verification by qualified user

FDA Submission Metadata

Submission number
K182181
Decision date
November 2018
FDA panel
Neurology
Product code
OMB
Clinical task (npj)
detection/diagnosis
Data modality (npj)
Signals

This entry is sourced from the FDA AI/ML-Enabled Medical Devices list. No editorial review yet — the catalogue may add a deeper review of this device in future.

View on FDA ›

This entry is on our editorial review queue. Full evaluation — performance metrics, clinical evidence, safety record — lands as our review pipeline graduates each device. The information above is what's been verified to date.